life sciences
- BIOTECHNOLOGY
- C&E Exclusion Filter
- C&E Industry News Filter
- cards
- Companies
- Content Types
- Corporate
- Corporate/Industrial News
- correct success
- credit
- credit score
- debit cards
- Defiance Next Gen SPAC Derived ETF
- disruptions
- docu
- docusign
- dump
- EARNINGS
- Economic News
- Factiva Filters
- federal reserve
- Finance
- Financial Performance
- Healthcare
- Healthcare/Life Sciences
- Hood
- Increases
- industrial news
- interest rates
- investors
- life sciences
- Looming
- Monetary Policy
- money
- MoneyLosing
- Nikola
- NKLA
- rate
- Rivian Automotive
- RIVN
- Robinhood Markets
- share price movement
- Share Price Movement/Disruptions
- Shares
- SPAK
- SYND
- WSJ-PRO-WSJ.com


Moonshot stocks are coming back to Earth. As the Federal Reserve moves closer to raising interest rates, investors are repricing their bets on one of the riskiest corners of the market: shares of companies that don’t make money. Cash-burning technology firms, biotechnology companies without any approved drugs and startups that listed quickly via mergers with […]
- BioNTech SE ADR
- Biotech and Pharma
- BNTX
- china
- clothing
- Clothing/Textiles
- Consumer Goods
- Coronavirus
- correct success
- Delays
- Entertainment
- epidemics
- facebook new name
- FB
- Finance
- Financial manageme
- Financial success
- General News
- Health
- Healthcare
- Healthcare/Life Sciences
- Immunizations
- Infectious Diseases
- life sciences
- March
- Markets
- Media
- Media/Entertainment
- Medical Conditions
- medical treatments
- Medical Treatments/Procedures
- medications
- meta
- meta facebook
- meta platforms
- Meta Platforms Inc
- moderna
- Moderna Inc
- money
- MRNA
- North America
- Novel Coronaviruses
- Office
- Omicron
- Online Service Providers
- outbreaks
- Outbreaks/Epidemics
- PFE
- Pfizer
- PFIZER INC
- Pharmaceuticals
- Political
- Political/General News
- Procedures
- ready
- Respiratory Tract Diseases
- Retail
- Retail/Wholesale
- return
- social media platforms
- Social Media Platforms/Tools
- specialized drugs
- Specialized Drugs/Medications
- SYND
- technology
- Textiles
- tools
- vaccine
- vaccines
- wholesale
- Wholesalers


Text size Pfizer says its Omicron-targeting vaccine should be ready by March. Patrick T. Fallon/AFP via Getty Images Pfizer said it should be able to launch a redesigned Covid-19 vaccine that targets the Omicron variant of the virus by March, while Facebook parent Meta Platforms delayed its U.S. office reopening plans and mandated booster shots […]
- article_normal
- Banking
- Banking/Credit
- bond markets
- BX:TMUBMUSD10Y
- C&E Exclusion Filter
- commercial banking
- commodity
- Commodity/Financial Market News
- comp
- Content Types
- credit
- Credit Suisse Group AG ADR
- CS
- DEBT
- Debt/Bond Markets
- DJIA
- Dow Jones Industrial Average
- epidemics
- Equity Markets
- Factiva Filters
- Finance
- financial market news
- Financial Services
- General News
- Health
- Healthcare
- Healthcare/Life Sciences
- Infectious Diseases
- Integrated Banks
- Investing
- Investing/Securities
- life sciences
- Medical Conditions
- medications
- NASDAQ Composite Index
- Novel Coronaviruses
- outbreaks
- Outbreaks/Epidemics
- Pharmaceuticals
- Political
- Political/General News
- Respiratory Tract Diseases
- S&P 500 Index
- securities
- specialized drugs
- Specialized Drugs/Medications
- spx
- U.S. 10 Year Treasury Note
- vaccines


After taking an initial wait-and-see approach on the new omicron variant of coronavirus, Credit Suisse CS, +3.57%, one of the world’s largest investment banks, now sees a “considerable” risk that the U.S. and large parts of Europe will be unable to avoid “stringent” lockdowns this winter. Credit Suisse’s view is at odds with that of […]
Pages
- 1